Hospital groups urged congressional leaders in a Sept. 24 letter to exclude language “that would negatively impact 340B” from major drug pricing reforms that could be voted on this week.
Hospitals Ask Hill Leaders to Shield 340B, as Vote Nears on Drug Pricing Reform
Six national hospital groups late last week urged Democratic and Republican congressional leaders to exclude language “that would negatively impact 340B” from major drug pricing reforms that could be voted on this week.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
